-+ 0.00%
-+ 0.00%
-+ 0.00%

Changes in Hong Kong stocks | Some innovative drug concept stocks rose higher in the afternoon, Kingsley Biotech (01548) rose nearly 8%, and Rongchang Biotech (09995) rose more than 4%

Zhitongcaijing·07/31/2026 05:57:01
Listen to the news

The Zhitong Finance App learned that some innovative drug concept stocks rose in the afternoon. As of press release, Jingtai Holdings (02228) rose 7.45% to HK$6.92; Kingsley Biotech (01548) rose 6.4% to HK$18.3; Rongchang Biotech (09995) rose 2.96% to HK$81.75; and Pharmaceutical Biotech (02269) rose 2.75% to HK$38.84.

According to the news, on July 30, the Shanghai Municipal People's Government issued the “Fifteenth Five-Year Plan” for the development of health care in Shanghai, which proposes increasing support for research and development of innovative pharmaceutical devices and clearly implementing DRG and DIP payment limit exclusion mechanisms for innovative drugs, sending a positive signal to the medical insurance payment environment for innovative pharmaceutical devices. Furthermore, innovative drugs were included in batches for the first time in the national essential drug catalogue, which is expected to enhance the clinical accessibility of domestically produced innovative drugs.